Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Publication : journal of clinical oncology

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma

Authors : Suzanne I.M. Neppelenbroek; Yvonne M. Geurts; Berthe M.P. Aleman ...

Subjects: Adult; 0301 basic medicine; Cancer Research

Source: J Clin OncolJournal of Clinical Oncology, 42, 16, pp. 1903-1913

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers

Authors : John Radford

Subjects: Antibiotics, Antineoplastic; Breast Neoplasms/drug therapy; Doxorubicin

Source: Radford, J 2024, ' Doxorubicin and Breast Cancer Risk : The Importance of Long-Term Follow-Up in Curable Cancers ', Journal of clinical

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial

Authors : Vincent Camus; Catherine Thieblemont; Philippe Gaulard ...

Subjects: [SDV] Life Sciences [q-bio]; [SDV]Life Sciences [q-bio]; Medizin

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, no. 14, p. 1612-1618 (2024)Journal

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Authors : Ingemar Lagerlöf; Helena Fohlin; Gunilla Enblad

Subjects: Cancer och onkologi; Kardiologi; ORIGINAL REPORTS

Source: J Clin Oncol

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Authors : Bielack, Stefan S; Smeland, Sigbjørn; Whelan, Jeremy S ...

Subjects: Medical and Health Sciences; Clinical Medicine; Cancer and Oncology

Source: Journal of Clinical Oncology. 33(20):2279-2287

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)

Authors : Kenzo Sonoda; Hitoshi Niikura; Noriyuki Katsumata ...

Subjects: Adult; Deoxycytidine; Polyethylene Glycols

Source: J Clin Oncol

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2

Authors : Ganz, Patricia A; Romond, Edward H; Cecchini, Reena S

Subjects: Clinical Research; Patient Safety; Breast Cancer

Source: Journal of Clinical Oncology. 35(35)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study

Authors : Jiani Hu; Meredith Faggen; Caroline Block

Subjects: Adult; Filgrastim; Paclitaxel

Source: J Clin Oncol

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Authors : Younes, Anas; Sehn, Laurie H; Johnson, Peter ...

Subjects: Adult; Aged, 80 and over; Male

Source: Journal of Clinical Oncology. 37:1285-1295

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

Authors : Paul K. Marcom; Andrew J. Goss; Claudine Isaacs

Subjects: Adult; Young Adult; Doxorubicin

Source: Journal of Clinical Oncology. 38:1539-1548

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma

Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers

Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)

Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

اتصل بنا

اتبع